Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease

8 months ago

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to…

Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds

8 months ago

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 11, 2025Idorsia Ltd (SIX: IDIA) announces the interim…

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

8 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am…

NING Service Experience Centers Launch in Shanghai and Bangkok, Setting a New Benchmark for the NEV Aftermarket

8 months ago

NINGDE, China, Aug. 10, 2025 /PRNewswire/ -- On August 10th, NING Service, an independent aftermarket brand under CATL, celebrated its first…

Enovix Shareholder Second Reminder: Early Warrant Expiration Price Condition

8 months ago

Enovix Warrants: 14 of 14 Trading Days Above $10.50 August 08, 2025 18:57 ET  | Source: Enovix Corporation FREMONT, Calif.,…

GVNR: Unlocking Permissionless, Peer-to-Peer Asset Control Across All Chains

8 months ago

Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Cross-chain infrastructure has long been burdened by bridge-related vulnerabilities, centralization risks, and fragmented…

Lexin Reports Q2 2025 Financial Results: Revenue Hits RMB 3.59B with 15.6% QoQ Growth; Profit Rises for 5 Straight Quarters as Scenario-Based Transactions Surge to Spur Consumption

8 months ago

Shenzhen, China , Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 7, 2025, Beijing time, Lexin (NASDAQ: LX), China’s leading…

Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements and Implementation of Cease Trade Order

8 months ago

August 08, 2025 18:28 ET  | Source: Aja Health and Wellness Inc. Not for dissemination in the United States of…

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

8 months ago

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8 months ago

August 08, 2025 17:00 ET  | Source: TELA Bio, Inc. MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…